MENEGHETTI, FIORELLA
MENEGHETTI, FIORELLA
Dipartimento di Scienze Farmaceutiche
(E)-2-{[1-(3,11-Dimethyl-4-methylene-10-oxo-1-phenyl-4,5,10,11-tetrahydro-1H-benzo[b]pyrazolo[3,4-f][1,5]diazocin-5-yl)ethylidene]amino}-N-methyl-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)benzamide
2013 F. Meneghetti, B. Maggio
(S)-Pramipexole and Its Enantiomer, Dexpramipexole : a New Chemoenzymatic Synthesis and Crystallographic Investigation of Key Enantiomeric Intermediates
2020 S. Ciceri, P. Ferraboschi, P. Grisenti, S. Reza Elahi, C. Castellano, M. Mori, F. Meneghetti
1,4-dimethyl-3-phenyl-3H-pyrazolo[3,4-c]isoquinolin-5(4H)-one
2008 F. Meneghetti, G. Bombieri, G. Daidone, B. Maggio
3-(4-Chlorophenyldiazenyl)-1-methyl-1,4,5,6-tetrahydropyridine
2008 F. Meneghetti, G. Bombieri, M. Tonelli
5,6-Dimethyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole-2,2-dioxide as new STAT3 inhibitor
2019 S. Villa, M. Mori, F. Meneghetti, A. Pedretti, L. Regazzoni, D. Colombo, A. Asai, A. Gelain
5-(4-Nitrophenyl)furan-2-carboxylic Acid
2022 M. Mori, A. Tresoldi, S. Villa, G. Cazzaniga, M. Bellinzoni, F. Meneghetti
6-Chloro-1-(3,5-dimethylphenylsulfonyl)-1,3-dihydro-2H-benzimidazol-2-one
2008 F. Meneghetti, G. Bombieri, P. Logoteta, L. De Luca
6-Chloropyridazin-3yl derivatives active as nicotinic agents: X-ray structures of [3-(6- Chloropyridazin-3yl)-N,N-dimethylpiperazine]I (1) and [3-(6-Chloropyridazin-3yl)-N,N-dimethylhomopiperazine]I (2)
2002 R. Artali, D. Barlocco, G. Bombieri, F. Meneghetti
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid
2020 M. Mori, F. Meneghetti, L.R. Chiarelli, A. Diego, D. Nava, A. Gelain, G. Cazzaniga, S. Villa, E.R.E. Pini
A click chemistry approach to explore a new scaffold for potential antitubercular agents
2018 M. Mori, S. Villa, A. Gelain, L.R. Chiarelli, F. Meneghetti
A combined theoretical and X-ray study on two Gadolinium isomeric derivatives as MRI contrast agents: Na[Gd(H2O)L] ∙3H2O
2009 R. Artali, G. Bombieri, F. Meneghetti, D. Palano, P. Morosini, M. Galli
A complete characterization of the 3D properties of the CCR5 antagonist Vicriviroc
2012 L. Legnani, D. Colombo, F. Meneghetti, S. Villa, L. Toma
A crystallographic study of new Cu(II) and Ln(III) complexes as contrast agents for MRI
2008 G. Bombieri, F. Meneghetti, R. Artali, Z. Baranyai, M. Botta, S. Aime
A crystallographic study of novel antagonists at NMDA receptor
2006 F. Meneghetti, R. Artali, G. Roda, G. Bombieri
A crystallographic study on novel 2-(5-phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole derivatives having antimitotic properties
2009 F. Meneghetti, F. Caminiti, D. Masciocchi, F. Zambianchi, S. Villa
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors
2020 G. Cazzaniga, M. Mori, A. Gelain, E. Pini, G. Stelitano, L.R. Chiarelli, F. Meneghetti, S. Villa
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2017 F. Porta, A. Gelain, D. Barlocco, N. Ferri, S. Marchiano', V. Cappello, L. Basile, S. Guccione, F. Meneghetti, S. Villa
A multicomponent reaction among Z-chlorooximes, isocyanides, and hydroxylamines as iper-nucleophile third component. A one-pot access to aminodioximes and their subsequent transformation to 1,2,4-oxadiazole-5-amines through a Mitsunobu-Beckmann rearrangement
2015 V. Mercalli, A. Massarotti, M. Varese, M. Giustiniano, F. Meneghetti, E. Novellino, G.C. Tron
A new Cu(II)-EBTA complex for nuclear medicine
2008 F. Meneghetti, R. Artali, Z. Baranyai, G. Bombieri, M. Botta
A solution thermodynamic study of the Cu(II) and Zn(II) complexes of EBTA : X-ray crystal structure of the dimeric complex [Cu-2(EBTA)(H2O)(3)](2)
2009 Z. Baranyai, G. Bombieri, F. Meneghetti, L. Tei, M. Botta